DarioHealth Corp

NASDAQ:DRIO  
15.61
-0.40 (-2.50%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)252.60M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$6.61 Million
Adjusted EPS-$1.14
See more estimates
10-Day MA$16.35
50-Day MA$15.49
200-Day MA$17.67
See more pivots

DarioHealth Corp Stock, NASDAQ:DRIO

142 West 57th Street, 8th floor, New York, New York 10019
United States of America
Phone: +1.833.914.3796
Number of Employees: 127

Description

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. The firm solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.